Clinical trial · Observational
Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study
Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients Within the Veneto Oncology Network: the ROVID Study
NCT04811781CI-TRIAL-00070977completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumor, Adult | Adult Solid Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Cancer Patients with SARS-COV-2 infection.
Primary outcomes (1)
- measure
- The rate of SAR-COV2 infection development in association with tumor characteristics.
- timeFrame
- through study completion, an average of 18 months.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * be 18 Years and older * cancer patients belonging to Veneto 's Oncological Network * Patients with SAR COV-2 infection Exclusion Criteria: * Patients with no SAR COV2 Infection * Volunteers * No Cancer Patients
References
Publications (0)
Data not yet available
No reference posted for this study.